1. Academic Validation
  2. Discovery and the structural basis of a novel p21-activated kinase 4 inhibitor

Discovery and the structural basis of a novel p21-activated kinase 4 inhibitor

  • Cancer Lett. 2014 Jul 10;349(1):45-50. doi: 10.1016/j.canlet.2014.03.024.
Byung Jun Ryu 1 Sunmin Kim 2 Bora Min 3 Keon Young Kim 2 Jin Soo Lee 4 Whui Jung Park 4 Hyuk Lee 3 Seong Hwan Kim 5 SangYoun Park 6
Affiliations

Affiliations

  • 1 Laboratory of Translational Therapeutics, Korea Research Institute of Chemical Technology, Yuseong-Gu, Daejeon 305-600, Republic of Korea.
  • 2 School of Systems Biomedical Science, Soongsil University, Seoul 156-743, Republic of Korea.
  • 3 Medicinal Chemistry Research Center, Korea Research Institute of Chemical Technology, Yuseong-Gu, Daejeon 305-600, Republic of Korea.
  • 4 Research Institute, DongWha Pharm. Co., Gyeonggi-do 446-902, Republic of Korea.
  • 5 Laboratory of Translational Therapeutics, Korea Research Institute of Chemical Technology, Yuseong-Gu, Daejeon 305-600, Republic of Korea. Electronic address: hwan@krict.re.kr.
  • 6 School of Systems Biomedical Science, Soongsil University, Seoul 156-743, Republic of Korea. Electronic address: psy@ssu.ac.kr.
Abstract

Functional versatility and elevated expression in cancers have endowed p21-activated kinase 4 (PAK4) as one of the first-in-class anti-cancer drug target. In this study, a novel PAK4 Inhibitor, KY-04031 (N(2)-(2-(1H-indol-3-yl)ethyl)-N(4)-(1H-indazol-5-yl)-6-methoxy-1,3,5-triazine-2,4-diamine), was discovered using a high-throughput screening. Analysis of the complex crystal structure illustrated that both indole and indazole of KY-04031 are responsible for PAK4 hinge interaction. Moreover, the molecule's triazine core was found to mimic the ribose of the natural ATP substrate. The cell-based anti-cancer potency of KY-04031 was less effective than the pyrroloaminopyrazoles; however, the unique molecular feature of KY-04031 can be exploited in designing new PAK4 inhibitors.

Keywords

Cancer; Drug discovery; HTS; PAK4; Protein kinase; X-ray crystallography.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-124764
    PAK4抑制剂
    PAK